Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3064-2026

Johnson & Johnson Surgical Vision, Inc. recalls HEALON EndoCoat PRO

Johnson & Johnson Surgical Vision, Inc.Irvine, CA, United StatesReported Sep 9, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion conditions (i.e. insertion angle, incision size, etc.) before proceeding because forcing the cannula may cause corneal abrasion, iris trauma or descemet's membrane detachment.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

HEALON EndoCoat PRO3 codes
  • 10300012 (US/CAN) HEALON DUET PRO II
  • 10300016 (US/CAN) HEALON EndoCoat PRO
  • 10301012 (EU)
HEALON DUET PRO II1 code
  • 10301016 (EU)

Lot / code information

Lot #
10300012/5050474755093/UA32232, UA32250, UA32268, UA32290, UA32292, UA32303 — +16 moreShow all
10300012/5050474755093/UA32232, UA32250, UA32268, UA32290, UA32292, UA32303, UA32371, UP31203, UP31205; 10300016/5050474755116/UA32447, UA32448, UA32449, UB33008, UB33026, UB33082, UB33083, UB33175; 10301012/5050474755109/UB33014, UB33041, UB33057, UB33060, UB33100, UB33190; 10301016/5050474755123/UB33084, UB33194

What the firm is doing

On 7/31/2026, correction notices were mailed to customers and distributors informing them of the following: Device Insertion Technique Clarification: If resistance is encountered during insertion, withdraw the cannula and reassess the insertion conditions (i.e. insertion angle, incision size, etc.) before proceeding. Do not force the cannula through the incision, as this may increase the risk of unintended tissue injury, including, but not limited to corneal abrasion, iris trauma or Descemet s Membrane Detachment, which may require medical or surgical intervention to preclude serious injury. This investigation is currently ongoing, and we will notify users if any additional information comes to light. 1) Forward this notice to all surgeons using this device in your facility. 2) If any of the subject product has been transported to another facility/surgeon, contact that facility/surgeon and provide/forward this notice to them. 3) Keep a copy of this notice with the subject product. 4) Complete, sign, and return the Business Reply Form via email to RegCompliOne@its.jnj.com If you have questions or concerns with regard to this notification, please contact the firm's Global Post Market Safety Team at 1-877-266-4543, Option 2. Additional notices with additional affected devices to be sent in the future.

DistributionShow details

Worldwide - US Nationwide distribution including in the states of PA, AL, AZ, AR, CA, FL, IL, IN, IA, KY, LA, ME, MI, MN, MS, NJ, NY, NC, OH, OR, TN, TX, WA, WV, HI, CO, MD, VA, WI, ID, NH, SD, OK, MA, NM, DE, GA, SC, CT, NV, MO, RI, KS, ND and the countries of CA, BE, CH, DE, DK, ES, FR GB, HU, IS, IT, NL, NO, PT, SE.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls